Graduate Curriculum Committee Course Proposal Form
for Courses Numbered 5000 and Higher
Note: Before completing this form, please carefully read the accompanying instructions.
Submission guidelines are posted to the GCC Web site: http://www.ecu.edu/cs-acad/gcc/index.cfm
1. Course prefix and number:
NURS 6419
2. Date:
1-13-2014
3. Requested action:
New Course
x
Revision of Active Course
Revision & Unbanking of a Banked Course
Renumbering of an Existing Course from
from
to
#
x
Required
#
Elective
4. Method(s) of delivery (check all boxes that apply for both current/proposed and expected
future delivery methods within the next three years):
Current or
Proposed Delivery
Method(s):
Expected
Future Delivery
Method(s):
On-campus (face to face)
Distance Course (face to face off campus)
x
Online (delivery of 50% or more of the instruction is offered online)
x
5. Justification. Identify the committee or group (e.g., Graduate faculty of the Department of
English) that conducted the assessment of curriculum and student learning. Explain why the
unit wishes to offer or revise the course. Include specific results from the unit assessment that
led to the development or modification of the course. If applicable, cite any accrediting
agency/ies and reference the specific standard/s.
The Advanced Practice Registered Nurse (APRN) Consensus Model stipulates that the
concentration-specific core course that focuses on advanced pharmacology must include
the study of pharmacodynamics, pharmacokinetics and pharmacotherapeutics of all broad
categories of agents across the lifespan. In addition to this broad-based content,
population-focused content must be included relative to the neonate and pediatric patient
through two years of age. Therefore, curriculum development was ensued to realign this
course with the American Association of Colleges of Nursing (AACN) accreditation
requirements. General core course content will include the assessment, diagnosis, and
pharmacologic management of health problems in a safe, high quality, cost-effective
manner. Population-specific foci will include the study of neonatal and pediatric
pharmacodynamics, pharmacokinetics, monitoring for therapeutic response to
pharmacological agents, and legal implications for prescriptive practices for the neonatal
Approved by GCC April 2012; posted summer of 2012
nurse practitioner.
6. Course description exactly as it should appear in the next catalog:
NURS 6419 – Clinical Pharmacology for Advanced Nursing Practice Across the
Lifespan
3
May be repeated upon readmission to the concentration. P: Admission to NURS graduate
program or consent of instructor. Scientific inquiry relative to the pharmacodynamics,
pharmacokinetics and pharmacotherapeutics of broad categories of agents across the
lifespan, with emphasis on the neonate and pediatric patient.
7. If this is a course revision, briefly describe the requested change:
Revisions to course name, course description, topical outline, and required textbooks.
8. Course credit:
Lecture Hours
3
3
Weekly
OR
Per Term
Credit Hours
Lab
Weekly
OR
Per Term
Credit Hours
s.h.
Studio
Weekly
OR
Per Term
Credit Hours
s.h.
Practicum
Weekly
OR
Per Term
Credit Hours
s.h.
Internship
Weekly
OR
Per Term
Credit Hours
s.h.
Other (e.g., independent study) Please explain.
s.h.
3
Total Credit Hours
9. Anticipated annual student enrollment:
18
10. Changes in degree hours of your programs:
Degree(s)/Program(s)
Changes in Degree Hours
MSN Neonatal Nurse
Practitioner
none
11. Affected degrees or academic programs, other than your programs:
Degree(s)/Program(s)
Changes in Degree Hours
n/a
n/a
12. Overlapping or duplication with affected units or programs:
x Not applicable
Documentation of notification to the affected academic degree programs is
attached.
13. Council for Teacher Education (CTE) approval (for courses affecting teacher education):
x Not applicable
Approved by GCC April 2012; posted summer of 2012
s.h.
s.h.
Applicable and CTE has given their approval.
14. University Service-Learning Committee (USLC) approval:
x Not applicable
Applicable and USLC has given their approval.
15. Statements of support:
a. Staff
x Current staff is adequate
Additional staff is needed (describe needs in the box below):
b. Facilities
x Current facilities are adequate
Additional facilities are needed (describe needs in the box below):
c. Library
x
Initial library resources are adequate
Initial resources are needed (in the box below, give a brief explanation and an
estimate for the cost of acquisition of required initial resources):
d. Unit computer resources
x
Unit computer resources are adequate
Additional unit computer resources are needed (in the box below, give a brief
explanation and an estimate for the cost of acquisition):
e. ITCS resources
x
ITCS resources are not needed
The following ITCS resources are needed (put a check beside each need):
Mainframe computer system
Statistical services
Network connections
Computer lab for students
Software
Approval from the Director of ITCS attached
16. Course information (see: Graduate Curriculum and Program Development Manual for
instructions):
a. Textbook(s) and/or readings: author(s), name, publication date, publisher, and
city/state/country. Include ISBN (when applicable).
Approved by GCC April 2012; posted summer of 2012
Required Text Books
American Psychological Society. (2009). Publication manual of the American
Psychological Society (6th ed.). Washington, DC: Author. ISBN# 9781433805615
Yaffe, S. J., & Aranda, J. V. (Eds.). (2011). Neonatal and pediatric
pharmacology: therapeutic principles in practice (4th ed.).
Philadelphia, PA: Lippincott Williams & Wilkins. ISBN# 9780781795388
Taketomo, C.K., Hodding, J.H., Kraus, D.M. (2013-2014). Pediatric & neonatal
dosage handbook (20th ed.). Hudson, OH: Lexicomp. ISBN# 9780916589448
b. Course objectives for the course (student – centered, behavioral focus)
If this is a 5000-level course that is populated by undergraduate and graduate students,
there must be differentiation in the learning objectives expected.
Upon completion of this course, students will be able to:
1. Apply the principles of pharmacokinetics and pharmacodynamics in selecting
pharmacologic therapies across the lifespan, with emphasis on neonates and
pediatric patients up to two years of age.
2. Analyze the relationship between pharmacologic agents and physiologic/pathologic
responses in patients with specific acute and chronic health problems across the
lifespan with emphasis on neonates and pediatric patients up to two years of age.
3. Evaluate the effects of single and multiple drug regimens including drug
interactions and adverse drug reactions.
4. Identify pharmacological regimens for the management of common health
problems affecting neonates and pediatric patients with consideration for patient
variations, safety, efficacy, standard of care, cost-effectiveness and the family unit.
5. Discuss the legal parameters and standards of care when prescribing, administering,
and monitoring pharmacological interventions.
6. Investigate the Centers for Disease Control recommendations for immunizations
across the lifespan.
c. Course topic outline
The list of topics should reflect the stated objectives.
I.
II.
III.
IV.
Prescriptive Authority for the Advanced Practice Nurse (Obj. 4, 5)
a. Legal parameters
b. Standards of care for prescribing and administering pharmacological
interventions
c. Prescribing and record keeping practices, per State and Federal
regulations and the advanced practice nurse collaborative practice
agreement
d. Cost-effectiveness, safety, and efficacy: “Primum Non Nocere”
Principles of pharmacodynamics across the lifespan (Obj. 1)
Principles of pharmacokinetics across the lifespan (Obj. 1)
a. Absorption, distribution, metabolism, and excretion
Fundamentals of pharmacological interventions (Obj. 1, 4, 5)
Approved by GCC April 2012; posted summer of 2012
V.
VI.
a. Interactions, reactions, side effects, incompatibilities, indications, and
contraindications
b. The effect of pharmacologic interventions on the family unit
c. Considering safety, efficacy, standard of care, and cost
Population-Specific Content: the neonate, pediatric patient and implications for
families (as appropriate) (Obj. 1, 2, 3, 4, 5)
a. Drug absorption: oral, topical, intramuscular
b. Drug distribution
c. Drug metabolism: the impact of acceptor proteins
d. Drug elimination: first-order kinetics
e. Pregnancy and pharmacology: The impact of maternal ingestion of
drugs on the fetus and neonate
f. Antenatal corticosteroids
g. Pharmacologic agents and neonatal resuscitation
h. Pharmacological regimens with investigation of physiologic/pathologic
responses, single and multi-drug regimens, and safety, efficacy,
standards of practice and cost-effectiveness.
i. Central Nervous System: methylxanthines, anti-epileptics,
muscle relaxants
ii. Respiratory System: Surfactant, Nitric Oxide, Vitamin A,
Bronchodilators, diuretic therapy, corticosteroids
iii. Cardiovascular System: Sildenafil, inotropic agents,
antiarrhythmic agents, non-steroidal anti-inflammatory drugs,
alprostadil
iv. Gastrointestinal System: histamine receptor agonists, proton
pump inhibitors, prokinetics
Infectious Diseases and Pharmacologic/Preventative Strategies: Integrating
physiology and pathology in the selection, implementation, and evaluation of
efficacy with pharmacologic interventions (Obj. 1, 2, 3, 4, 5, 6)
a. CDC recommended immunization schedule across the lifespan: legal
implications for parental refusal of childhood immunizations
b. Treatment of common bacterial infections
c. Neonatal eye infections
d. Fungal infections
e. Viral infections
d. List of course assignments, weighting of each assignment, and grading/evaluation system
for determining a grade
MSN Essentials Reflective Statement……………………………………....5%
Discussion Board Participation…………..…………………………….…..10%
Case Study……..……………….………..………………………………....20%
Unit Quizzes (3 quizzes, each worth 10%)……….………….…………….30%
Final Exam…...…………………..………………………………………...35%
TOTAL: 100%
Approved by GCC April 2012; posted summer of 2012
Grading:
A course grade of B or above is required to progress in the NNP concentration
100-90%....................A
89.9-80%...................B
79.9-70%...................C
69.9-0%.....................F
Approved by GCC April 2012; posted summer of 2012